SHR-A1811 for Injection: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
3
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 2 1
Phase 3 1
Conditions being studied
| Condition | Trials |
|---|---|
| Breast cancer | 2 |
| HER2 Low Breast Carcinoma | 1 |
| PD-L1-positive Locally Recurrent Unresectable or Metastatic Triple-negative Breast Cancer | 1 |
Recruiting trials involving SHR-A1811 for Injection
- A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer
- A Study of SHR-A1811 as Neoadjuvant Treatment for Patients With HR-Positive, Low HER2 Expression Breast Cancer
Common questions
How many recruiting trials involve SHR-A1811 for Injection?
2 recruiting trials across 3 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.